Organon y Lilly suscriben acuerdo de comercialización para dos medicamentos contra la migraña en Europa - Iberonews iberonews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iberonews.com Daily Mail and Mail on Sunday newspapers.
Organon & Lilly Enter Commercialization Agreement in Europe for Two Migraine Medicines - Iberonews iberonews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iberonews.com Daily Mail and Mail on Sunday newspapers.
Organon & Co.: Organon & Lilly Enter Commercialization Agreement in Europe for Two Migraine Medicines finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Organon becomes the sole distributor and promoter of Emgality® and RAYVOW™ in Europe, building on strong commercial expertise in central nervous system disorders
Expands Organon’s European.